Search results
Showing 1 to 15 of 40 results for colonoscopy
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
Around 100,000 fewer colonoscopies expected to take place each year following updated NICE guidance
Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care
Doctors have been advised to offer people with signs or symptoms of colorectal cancer a home test to reduce the waiting times for a colonoscopy, NICE has said in draft guidance.
Find out more about the progress made in implementing NICE guidance on diagnostic pathology
This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early bowel cancer in adults most at risk.
Faecal microbiota transplant for recurrent Clostridioides difficile infection (MTG71)
Evidence-based recommendations on faecal microbiota transplant for recurrent Clostridioides difficile infection.
View recommendations for MTG71Show all sections
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
This quality standard covers the management of colorectal (bowel) cancer in adults. It includes managing local disease and secondary tumours (metastatic disease). It describes high-quality care in priority areas for improvement.
View quality statements for QS20Show all sections
Sections for QS20
- Quality statements
- Quality statement 1: Testing for Lynch syndrome
- Quality statement 2: Discussion about treatment options for early rectal cancer
- Quality statement 3: Testing to guide systemic anti-cancer treatment
- Quality statement 4: Follow-up for detecting local recurrence and distant metastases
- Update information
- About this quality standard
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and secondary tumours (metastatic disease).
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)
Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer
continued for many years after people stopped taking aspirin. Regular colonoscopies, to spot cancers early if they develop, are...
Audit Prize (2nd Place) Award 2019. NICE CG118 guidance recommends using colonoscopy to check for signs of bowel cancer in people aged...
This guideline covers the diagnosis and management of diverticular disease in people aged 18 years and over. It aims to improve diagnosis and care and help people get timely information and advice, including advice about symptoms and when to seek help.